Anticancer Research: 43 (10)

October 2023; Volume 43,Issue 10

Letter to the Editor

Open Access
From Mendel to Gene Therapy
SAMANTHA L. JEFFREY, DON A. BRIGHAM, SANT P. CHAWLA, NOAH FEDERMAN, FREDERICK L. HALL and ERLINDA M. GORDON

Anticancer Research October 2023, 43 (10) 4257-4261; DOI: https://doi.org/10.21873/anticanres.16620

Reviews

Open Access
The Influence of Statin Use on Chemotherapeutic Efficacy in Studies of Mouse Models: A Systematic Review
ANGELA TULK, RAJ WATSON and JENNIFER ERDRICH

Anticancer Research October 2023, 43 (10) 4263-4275; DOI: https://doi.org/10.21873/anticanres.16621
Open Access
High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy
TAKASHI HIGUCHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, SHINJI MIWA, KENTARO IGARASHI, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN

Anticancer Research October 2023, 43 (10) 4277-4284; DOI: https://doi.org/10.21873/anticanres.16622
Open Access
Surgery for Hepatocellular Carcinoma With Macroscopic Vascular Invasion in the Era of Modern Molecular Therapy
KENSUKE YAMAMURA, TORU BEPPU, TATSUNORI MIYATA, KOSUKE MIMA, HIROHISA OKABE, HIDETOSHI NITTA, KATSUNORI IMAI, HIROMITSU HAYASHI, ERI ODA, RYUICHI KARASHIMA, NOBUYUKI OZAKI and TAKATOSHI ISIKO

Anticancer Research October 2023, 43 (10) 4285-4293; DOI: https://doi.org/10.21873/anticanres.16623
Open Access
Biology and Management of Deep-seated Atypical Lipomatous Tumor of the Extremities
JUN NISHIO, SHIZUHIDE NAKAYAMA, YOSHIRO CHIJIIWA and MIKIKO AOKI

Anticancer Research October 2023, 43 (10) 4295-4301; DOI: https://doi.org/10.21873/anticanres.16624
Open Access
Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis
FAUSTO PETRELLI, CARMEN REA, MARIA CHIARA PARATI, KAREN BORGONOVO, MARA GHILARDI, LORENZO DOTTORINI, ANDREA LUCIANI, MICHELE GHIDINI, FIORELLA RUATTA, ORNELLA GARRONE and GIANLUCA TOMASELLO

Anticancer Research October 2023, 43 (10) 4303-4313; DOI: https://doi.org/10.21873/anticanres.16625
Open Access
Vascular Endothelial Growth Factor Family and Head and Neck Squamous Cell Carcinoma
CRISTINA-STEFANIA DUMITRU and MARIUS RAICA

Anticancer Research October 2023, 43 (10) 4315-4326; DOI: https://doi.org/10.21873/anticanres.16626
Open Access
Circulating Tumor Cells and Tumor Progression, Metastasis, and Poor Prognosis in Patients With Neuroblastoma
MASATO KOJIMA and EISO HIYAMA

Anticancer Research October 2023, 43 (10) 4327-4331; DOI: https://doi.org/10.21873/anticanres.16627

Experimental Studies

Open Access
Oleuropein Induces Cytotoxicity and Peroxiredoxin Over-expression in MCF-7 Human Breast Cancer Cells
KATHERINE JUNKINS, MARGARET RODGERS and SHELLEY A. PHELAN

Anticancer Research October 2023, 43 (10) 4333-4339; DOI: https://doi.org/10.21873/anticanres.16628
Open Access
Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS^G12D Inhibitor, in Colorectal Cancer Treatment
MASAHIRO KATAOKA, MASATO KITAZAWA, SATOSHI NAKAMURA, MAKOTO KOYAMA, YUTA YAMAMOTO, SATORU MIYAZAKI, NAO HONDO, HIROKAZU TANAKA and YUJI SOEJIMA

Anticancer Research October 2023, 43 (10) 4341-4348; DOI: https://doi.org/10.21873/anticanres.16629
Open Access
Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus
YUKO NAKAYAMA, DAICHI ENOMOTO, KAZUHIRO YAMAMOTO and KOHJI TAKARA

Anticancer Research October 2023, 43 (10) 4349-4357; DOI: https://doi.org/10.21873/anticanres.16630
You have access
Impact of SMAD2 and MET Expression on Lymph Node Metastasis of HER2-positive Gastric Cancer Cells
GEN TSUJIO, MASAKAZU YASHIRO, TAKASHI SAKUMA, RIKA AOYAMA, KOJI MARUO, YURIE YAMAMOTO and KIYOSHI MAEDA

Anticancer Research October 2023, 43 (10) 4359-4364; DOI: https://doi.org/10.21873/anticanres.16631
You have access
PD-L1 mRNA Detection in Immunohistochemically Negative Patients: A Complementary Method for a Better Treatment Selection?
ULRICH SOMMER, MARIANNE GROSSER, DANIELA AUST, KORINNA JOEHRENS, KATHARINA BOEHM, CHRISTIAN THOMAS, PIA HOENSCHEID, HOLGER H.H. ERB and GUSTAVO B. BARETTON

Anticancer Research October 2023, 43 (10) 4365-4371; DOI: https://doi.org/10.21873/anticanres.16632
You have access
Development of Polyethylene Glycol-based Hydrogels Optimized for In Vitro 3D Culture of HepG2 Hepatocarcinoma Cells
YOUNG JAE LEE, KEUN CHEON KIM, JEONG MIN LEE, JEONG MOOK LIM and SEUNG TAE LEE

Anticancer Research October 2023, 43 (10) 4373-4377; DOI: https://doi.org/10.21873/anticanres.16633
You have access
miR-122-5p Restrains Pancreatic Cancer Cell Growth and Causes Apoptosis by Negatively Regulating ASCT2
PING REN, NA WU, SHICHEN FU, WENBIN WANG, QI LI and QINGZHOU CHENG

Anticancer Research October 2023, 43 (10) 4379-4388; DOI: https://doi.org/10.21873/anticanres.16634
You have access
Targeting SALL4 by Entinostat Inhibits the Malignant Phenotype of Gastric Cancer Cells by Reducing EMT Signaling
LINLIN DU, FEI XIE, HAIBO HAN and LIANHAI ZHANG

Anticancer Research October 2023, 43 (10) 4389-4401; DOI: https://doi.org/10.21873/anticanres.16635
You have access
Unlocking Synergistic Potential: Enhancing Regorafenib Efficacy in Hepatocellular Carcinoma Through Combination Therapy With 18β-Glycyrrhetinic Acid
JR-DI YANG, PO-FU YUEH, TSAI LAN LIAO, YING-TZU CHEN, FEI-TING HSU, I-TSANG CHIANG, CHING MING CHANG and WEI-SHU WANG

Anticancer Research October 2023, 43 (10) 4403-4412; DOI: https://doi.org/10.21873/anticanres.16636
You have access
Melatonin Inhibits Gastric Cancer Cell Proliferation by Suppressing Exosome miR-27b-3p Expression
YI-QIANG ZHANG, SHUAI-SHUAI SHI, YUN-FEI LI, YANG YANG, PENG BAI and CHU-HAN QIAO

Anticancer Research October 2023, 43 (10) 4413-4424; DOI: https://doi.org/10.21873/anticanres.16637
You have access
The Effect of Respiratory Motion in Breast Intensity-modulated Radiation Therapy: 3D-Printed Dynamic Phantom Study
YOUNG EUN CHOI, KIHOON SUNG, KAP SANG DONG, HAN-BACK SHIN, HYUN JU KIM and YOUNG-KHI LIM

Anticancer Research October 2023, 43 (10) 4425-4433; DOI: https://doi.org/10.21873/anticanres.16638
You have access
High-throughput Sequencing Analysis of Differentially Expressed microRNAs Associated With SREBP1 in Differentiated Thyroid Carcinoma
JIATING ZHOU, JIANQIU LIU, KE ZHANG, JING LV, XIAOWEI PENG, JIE LIU and ZHI LI

Anticancer Research October 2023, 43 (10) 4435-4446; DOI: https://doi.org/10.21873/anticanres.16639
Open Access
Estrogen Effects Differ Between Medium Maintenance and Replacement from Transcriptional and Clinical Perspectives in T47D Breast Cancer Cells
SEOK-HOON JANG, SE HYUN PAEK, JONG-KYU KIM, JE KYUNG SEONG and WOOSUNG LIM

Anticancer Research October 2023, 43 (10) 4447-4469; DOI: https://doi.org/10.21873/anticanres.16640
You have access
Vitamin C Improves the Inhibitory Effects of Oxaliplatin on HCT-116 Colorectal Cancer Growth and Progression Through Cellular Oxidant Function-associated Cadherin Molecules
PORNNAPAT CHUSANGNIN, THARATHIP MUANGTHONG, WITCHUDA PAYUHAKRIT, SARAWOOT PALIPOCH and PRASIT SUWANNALERT

Anticancer Research October 2023, 43 (10) 4461-4472; DOI: https://doi.org/10.21873/anticanres.16641
You have access
Immune Cell Infiltration and Clinical Significance of Angiogenesis-related Genes in Lung Adenocarcinoma
QI ZHAO, WEIXING REN, SHUPING GAO and NAN MU

Anticancer Research October 2023, 43 (10) 4473-4489; DOI: https://doi.org/10.21873/anticanres.16642
You have access
Comprehensive Analysis of KREMEN2 as an Immunotherapeutic and Prognostic Biomarker in Pan-Cancer
JIN LIU, BIN ZHU, JIADI CHEN and YINGPING CAO

Anticancer Research October 2023, 43 (10) 4491-4509; DOI: https://doi.org/10.21873/anticanres.16643

Clinical Studies

Open Access
The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients
MICHAEL TASSAVOR, BRIAN J. MARTIN and ALEX M. GLAZER

Anticancer Research October 2023, 43 (10) 4511-4516; DOI: https://doi.org/10.21873/anticanres.16644
Open Access
Clinicopathological Characteristics, Survival Outcomes, and Prognostic Factors in Adult Patients With Sinonasal Rhabdomyosarcoma: Insights from a Retrospective Cohort Study
MONIKA DURZYNSKA, FLORENTINO LUCIANO CAETANO DOS SANTOS and IRMINA MARIA MICHALEK

Anticancer Research October 2023, 43 (10) 4517-4524; DOI: https://doi.org/10.21873/anticanres.16645
Open Access
Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma – A Single Center Analysis
NAEMI GLASER, ANNE PETZOLD, ANJA WESSELY, MATTHIAS D. KAUFMANN, ELIAS A.T. KOCH, HARALD KNORR, CAROLINE VOSKENS, MARKUS V. HEPPT, CAROLA BERKING and MICHAEL ERDMANN

Anticancer Research October 2023, 43 (10) 4525-4532; DOI: https://doi.org/10.21873/anticanres.16646
Open Access
Serum Creatinine Elevation as a Risk Factor for Niraparib-induced Hematologic Toxicity
KOKI HASHIMOTO, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, NAOKI SHIBATA, AZUSA SOEJIMA, TAKAHITO SUGISAKI, YUKA MORI, HISANORI SHIMIZU, MAYU YUNOKAWA, HIROYUKI KANAO and MASAKAZU YAMAGUCHI

Anticancer Research October 2023, 43 (10) 4533-4541; DOI: https://doi.org/10.21873/anticanres.16647
Open Access
Outcomes of 30 Gy/5 Fr Hypofractionated Stereotactic Radiation Therapy for Small Brain Metastases (≤2 cm)
YOSHIHIRO KAWAI, SHUHEI ARAMAKI, TOMOSHIGE ISHIHARA, KOSUKE SUZUKI, TSUYOSHI OKAWA, ERIKO SATO, NAOFUMI OTA, TAKASHI KOSUGI, MORIKAZU AMANO and KENTA KONISHI

Anticancer Research October 2023, 43 (10) 4543-4549; DOI: https://doi.org/10.21873/anticanres.16648
You have access
Prognostic Implications of PRAME Expression and Clinicopathological Factors in Sinonasal Mucosal Melanoma: A Single-center Cohort Study of 30 Cases
MONIKA DURZYNSKA, FLORENTINO LUCIANO CAETANO DOS SANTOS, ALDONA MATUSZCZYK, EDYTA DEREZINSKA-WOLEK and IRMINA MARIA MICHALEK

Anticancer Research October 2023, 43 (10) 4551-4557; DOI: https://doi.org/10.21873/anticanres.16649
Open Access
Mesonephric-like Adenocarcinoma of the Uterine Corpus: Clinicopathological and Prognostic Significance of L1 Cell Adhesion Molecule (L1CAM) Over-expression
SUHO PARK, YUNJOO CHO and HYUN-SOO KIM

Anticancer Research October 2023, 43 (10) 4559-4571; DOI: https://doi.org/10.21873/anticanres.16650
Open Access
Initial-to-nadir Prostate-specific Antigen Ratio Predicts Response to First-line Enzalutamide in Metastatic Castration-resistant Prostate Cancer
YUJIRO NAGATA, KAZUMASA JOJIMA, TAKUO MATSUKAWA, IKKO TOMISAKI and NAOHIRO FUJIMOTO

Anticancer Research October 2023, 43 (10) 4573-4581; DOI: https://doi.org/10.21873/anticanres.16651
You have access
Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)
TOMOHIRO TAMURA, TAKESHI NUMATA, HIDETOSHI YANAI, RYOTA NAKAMURA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, SHINICHIRO OKAUCHI, NORIHIRO KIKUCHI, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, HIROAKI SATOH, HIROICHI ISHIKAWA, TAKAYUKI KABURAGI, TAKEO ENDO, TORU SAKAMOTO and NOBUYUKI HIZAWA

Anticancer Research October 2023, 43 (10) 4583-4591; DOI: https://doi.org/10.21873/anticanres.16652
You have access
Interval Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Ovarian Cancer: Report of a Single-center Experience
CHRYSOULA LIAKOU, ANASTASIOS PANDRAKLAKIS, MARIA-CLELIA LA RUSSA, HILARY TURNBULL, JOAQUIN NIETO, TIMOTHY DUNCAN, ADAM STEARNS and NIKOLAOS BURBOS

Anticancer Research October 2023, 43 (10) 4593-4599; DOI: https://doi.org/10.21873/anticanres.16653
You have access
Importance of Atezolizumab Plus Bevacizumab Combination Treatment as First-line Therapy for Immunological Changes in Patients With Unresectable Hepatocellular Carcinoma
KOJIRO KOBAYASHI, HIDENARI NAGAI, TEPPEI MATSUI, TAKAHISA MATSUDA and KOJI HIGAI

Anticancer Research October 2023, 43 (10) 4601-4609; DOI: https://doi.org/10.21873/anticanres.16654
You have access
The Efficacy and Safety of a Low Relative Dose Intensity of Cabazitaxel in Patients With Metastatic Castration-resistant Prostate Cancer
FUMIHIKO URABE, DAIGO KOBAYASHI, KOSUKE IWATANI, YU IMAI, HAJIME ONUMA, KOICHI AIKAWA, TAKAFUMI YANAGISAWA, KOJIRO TASHIRO, HIROSHI SASAKI, JUN MIKI, KENTA MIKI and TAKAHIRO KIMURA

Anticancer Research October 2023, 43 (10) 4611-4617; DOI: https://doi.org/10.21873/anticanres.16655
You have access
Role of Positive Biopsy Core Ratio in Prostate Cancer Patients
HIROSHI KANO, KOUJI IZUMI, RYUNOSUKE NAKAGAWA, REN TORIUMI, SHUHEI AOYAMA, TAIKI KAMIJIMA, TAKAFUMI SHIMADA, RENATO NAITO, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

Anticancer Research October 2023, 43 (10) 4619-4626; DOI: https://doi.org/10.21873/anticanres.16656
You have access
Effect of Positive Biopsy Core Rate on Low-dose-rate Brachytherapy Outcomes in Intermediate-risk Prostate Cancer
YOSHITO KUSUHARA, TOMOYA FUKAWA, TOMOHARU FUKUMORI, YOSHITERU UENO, KEI DAIZUMOTO, YUTARO SASAKI, RYOTARO TOMIDA, YASUYO YAMAMOTO, KUNIHISA YAMAGUCHI, CHISATO TONOISO, AKIKO KUBO, TAKASHI KAWANAKA, SHUNSUKE FURUTANI, HITOSHI IKUSHIMA, HIRO-OMI KANAYAMA and MASAYUKI TAKAHASHI

Anticancer Research October 2023, 43 (10) 4627-4635; DOI: https://doi.org/10.21873/anticanres.16657
You have access
Correlation Between Colposcopic Patterns and Histological Grade of Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study
ERMELINDA MONTI, CRISTINA MARIA MICHELA MATOZZO, GIULIA EMILY CETERA, EUGENIA DI LORETO, GIADA LIBUTTI, VERONICA BOERO, CARLOTTA CAIA, DANIELA ALBERICO and GIUSSY BARBARA

Anticancer Research October 2023, 43 (10) 4637-4642; DOI: https://doi.org/10.21873/anticanres.16658
You have access
Outcomes of Sentinel Lymph Node Biopsy for Patients With Node-positive Breast Cancer Treated With Neoadjuvant Chemotherapy
CALOGERO CIPOLLA, SALVATORE VIENI, ELEONORA D’AGATI, NELLO GRASSI, PIETRO GENOVA, GIUSEPPA GRACEFFA, PAOLO VIGNERI, VITTORIO GEBBIA and MARIA ROSARIA VALERIO

Anticancer Research October 2023, 43 (10) 4643-4649; DOI: https://doi.org/10.21873/anticanres.16659
You have access
Simultaneous vs. Sequential Boost for Adjuvant Breast Radiotherapy
MARIE C. EGGERT, STEFAN JANSSEN, NATHAN Y. YU and DIRK RADES

Anticancer Research October 2023, 43 (10) 4651-4655; DOI: https://doi.org/10.21873/anticanres.16660
You have access
Increased Incidence of Liver Metastases in Colorectal Versus Appendiceal Adenocarcinoma Peritonectomy Patients Despite Equivocal Survival
CELINE GARRETT, ADAM CRISTAUDO, SHOMA BARAT and DAVID L. MORRIS

Anticancer Research October 2023, 43 (10) 4657-4662; DOI: https://doi.org/10.21873/anticanres.16661
You have access
RBM17 Expression Is Associated With the Efficacy of ICI Monotherapy in NSCLC With Low PD-L1 Expression
HIROAKI NAGAMINE, MASAKAZU YASHIRO, NAOKI YOSHIMOTO, MOTOHIRO IZUMI, AKIRA SUGIMOTO, KENJI NAKAHAMA, KOICHI OGAWA, YOSHIYA MATSUMOTO, KENJI SAWA, YOKO TANI, HIROYASU KANEDA, SHIGEKI MITSUOKA, KAZUHIRO YAMADA, TETSUYA WATANABE, KAZUHISA AASAI, KAZUHIRO FUKUMURA, AKILA MAYEDA and TOMOYA KAWAGUCHI

Anticancer Research October 2023, 43 (10) 4663-4672; DOI: https://doi.org/10.21873/anticanres.16662
Open Access
Clinical Outcomes With Lenvatinib in Patients Previously Treated With Atezolizumab/Bevacizumab for Advanced Hepatocellular Carcinoma
HISANORI MUTO, TEIJI KUZUYA, NAOTO KAWABE, EIZABURO OHNO, KOHEI FUNASAKA, MITSUO NAGASAKA, YOSHIHITO NAKAGAWA, RYOJI MIYAHARA, TOMOYUKI SHIBATA, SENJU HASHIMOTO, YOSHIAKI KATANO and YOSHIKI HIROOKA

Anticancer Research October 2023, 43 (10) 4673-4682; DOI: https://doi.org/10.21873/anticanres.16663
You have access
A Novel Filtration Membrane for Clustered Circulating Tumor Cell Extraction: A Prospective Feasibility Study
NORIYOSHI SAWABATA, KOHEI MORITA, SHIGENOBU TATSUMI, TOMOMI FUJII, TAKESHI NISHIKAWA, TAKESHI KAWAGUCHI, TORU ARAKANE, YOSHIAKI TOMINAGA, HIROKAZU SAKAGUCHI, TARO KOBAYASHI, SHIGETO HONTSU, YOSHIFUMI YAMAMOTO, NOBUHIRO FUJIOKA, NORIKO OUJI-SAGESHIMA, TOSHIHIRO ITO and CHIHO OHBAYASHI

Anticancer Research October 2023, 43 (10) 4683-4690; DOI: https://doi.org/10.21873/anticanres.16664
You have access
Immunological Responses Associated With Neoadjuvant Therapy in the Tumor Microenvironment of Esophageal Squamous Cell Carcinoma
YUKA TAKEHARA, TOMOAKI TAMAKI, KOSAKU MIMURA, KATSUHARU SAITO, PRAJWAL NEUPANE, TAKESHI TADA, YOHEI WATANABE, SUGURU HAYASE, ZENICHIRO SAZE, YUYA YOSHIMOTO, HISASHI SATO, KOJI KONO and YOSHIYUKI SUZUKI

Anticancer Research October 2023, 43 (10) 4691-4700; DOI: https://doi.org/10.21873/anticanres.16665
You have access
Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective Study
NOBUKI FURUBAYASHI, AKINORI MINATO, TAKAHITO NEGISHI, NAOTAKA SAKAMOTO, YOOHYUN SONG, YOSHIFUMI HORI, TOSHIHISA TOMODA, HIROYUKI MASAOKA, MIRII HARADA, SHINGO TAMURA, HIROKI KOBAYASHI, KAEDE MORIHARA, KENTARO KUROIWA, NARIHITO SEKI, NAOHIRO FUJIMOTO and MOTONOBU NAKAMURA

Anticancer Research October 2023, 43 (10) 4701-4708; DOI: https://doi.org/10.21873/anticanres.16666
You have access
Impact of Genomic Alterations on the Clinical Outcome of Patients With Hepatitis B-related Hepatocellular Carcinoma Receiving Curative Surgery: A Retrospective Cohort Study
CHIH-CHI WANG, WEN-LANG FAN, TING-TING LIU, SEE-TONG PANG, JING-HOUNG WANG, CHAO-CHENG HUANG, ENG-YEN HUANG and YEN-HAO CHEN

Anticancer Research October 2023, 43 (10) 4709-4722; DOI: https://doi.org/10.21873/anticanres.16667
You have access
A Case of Anti-3-hydroxy-3-methylglutaryl-coenzyme A Reductase Myopathy Associated With Advanced Cervical Carcinoma
ARNAUD SAILLANT, MATHILDE RASCLARD, JEAN-BAPTISTE GAUME, ODILE SOUCHAUD and MATTHIEU BAINAUD

Anticancer Research October 2023, 43 (10) 4723-4727; DOI: https://doi.org/10.21873/anticanres.16668
You have access
Microsatellite Instability-high Signet Ring Cell Carcinoma of the Colon Treated With Immunotherapy: Report of a Case
KOTA ARIMA, NORIO UEMURA, KENGO TSUNEYOSHI, HIROSHI FUJITA, HIDEYUKI KUROKI, SHINICHIRO UEMURA, NORIHISA HANADA, HIDEO BABA and YOSHIHIRO KOMOHARA

Anticancer Research October 2023, 43 (10) 4729-4733; DOI: https://doi.org/10.21873/anticanres.16669
You have access
Effective Use of Bromelain and Acetylcysteine (BromAc^®) for Treatment of Perigastric Pseudomyxoma Peritonei: A Case Report
ELIZABETH SKALKOS, KERRY L. CHEN, RUWANTHI WIJAYAWARDANA and DAVID L. MORRIS

Anticancer Research October 2023, 43 (10) 4735-4738; DOI: https://doi.org/10.21873/anticanres.16670
You have access
Pediatric Spinal Giant Cell-rich Osteosarcoma: Case Report and Brief Literature Review
HIDENORI SUZUKI, HIROAKI IKEDA, NORIHIRO NISHIDA, MASAHIRO FUNABA, KAZUHIRO FUJIMOTO, RYUTA IWANAGA and TAKASHI SAKAI

Anticancer Research October 2023, 43 (10) 4739-4745; DOI: https://doi.org/10.21873/anticanres.16671

Abstracts of the 33rd Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)

Open Access
Abstracts of the 33rd Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)
Anticancer Research October 2023, 43 (10) 4747-4778; DOI: https://doi.org/10.21873/anticanres.16672

Corrigenda

Open Access
Corrigenda
Anticancer Research October 2023, 43 (10) 4779; DOI: https://doi.org/10.21873/anticanres.16673

Retraction

Open Access
Retraction
Anticancer Research October 2023, 43 (10) 4780; DOI: https://doi.org/10.21873/anticanres.16674

Main menu

User menu

Search

Table of Contents

Letter to the Editor

Reviews

Experimental Studies

Clinical Studies

Abstracts of the 33rd Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)

Corrigenda

Retraction

In this issue

Issue highlights

Jump to